31st December 2015 by Louise Hudman
This is a new guideline from NICE advising that ciclosporin ophthalmic emulsion (Ikervis) can be used for treating dry eye disease that hasn’t responded to artificial tears. It has an anti-inflammatory effect on the cornea and lacrimal gland. The marketing authorisation is for treating severe keratitis in adult patients with dry eye disease.
"I have been a member of the NASGP for the past nine years and have found the advice and support offered invaluable. NASGP passionately champions for safe and fair working conditions for locums, which is crucial in an age of increasing medical litigation.
LocumDeck is a must for every locum who just wants to get on with the job that they were trained to do."
Dr Fiona Munro, GP
